Leader Med-Biotech's ABHM Featured at Hubei Medical Tech Innovation Conference

       August 9, 2025 — At the Hubei Medical Technology Innovation Achievements Conference, hosted by China Media Group (CMG) and held this morning at 10:00 AM, a breakthrough product—Absorbable Bone Wound Hemostasis Mud (ABHM) —was unveiled as a key innovation. This advanced material, jointly developed by our company and Wuhan University Zhongnan Hospital, represents a major step forward in bone wound management.

       The Hemostasis Mud is a novel bone wound material that integrates rapid clotting, complete absorbability, and bone regeneration promotion into one advanced solution. Its key performance metrics surpass those of comparable international products.

       Currently, the product has officially entered multi-center clinical trials and is expected to launch in the market next year.